Cargando…

Implications of CRISPR/Cas9 system in Hypertension and its related diseases

Detalles Bibliográficos
Autores principales:	Sekar, Durairaj, Lakshmanan, Ganesh, M, Biruntha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347049/ https://www.ncbi.nlm.nih.gov/pubmed/32647313 http://dx.doi.org/10.1038/s41371-020-0378-5

Ejemplares similares

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer
por: Selvakumar, Sushmaa Chandralekha, et al.
Publicado: (2022)

Identification of miR-802-5p and its involvement in type 2 diabetes mellitus
por: Rajkumar, Kaushik Vishnu, et al.
Publicado: (2020)

Metagenomic discovery of novel CRISPR-Cas13 systems
por: Hu, Yanping, et al.
Publicado: (2022)

Genetic variation may confound analysis of CRISPR-Cas9 off-target mutations
por: Wang, Guanqun, et al.
Publicado: (2018)

CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
por: Shahzad, Faizan, et al.
Publicado: (2022)

CRISPR/Cas9 system and its applications in nervous system diseases
por: Jiang, Haibin, et al.
Publicado: (2023)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

Response to correspondence on “Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation”
por: Gurumurthy, Channabasavaiah B., et al.
Publicado: (2021)

CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
por: Yang, Weili, et al.
Publicado: (2016)

Response to “Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation”
por: Yang, Hui, et al.
Publicado: (2021)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Reprogrammable CRISPR/dCas9-based recruitment of DNMT1 for site-specific DNA demethylation and gene regulation
por: Lu, Anrui, et al.
Publicado: (2019)

Ethical implications of fighting malaria with CRISPR/Cas9
por: Patrão Neves, Maria, et al.
Publicado: (2017)

CRISPR-Cas12a-assisted nucleic acid detection
por: Li, Shi-Yuan, et al.
Publicado: (2018)

Craspase: A novel CRISPR/Cas dual gene editor
por: Huo, George, et al.
Publicado: (2023)

Disabling of ARC1 through CRISPR–Cas9 leads to a complete breakdown of self-incompatibility responses in Brassica napus
por: Abhinandan, Kumar, et al.
Publicado: (2022)

CRISPR-Cas9-mediated editing of the OsHPPD 3′ UTR confers enhanced resistance to HPPD-inhibiting herbicides in rice
por: Wu, Yunyu, et al.
Publicado: (2023)

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications
por: Spalato-Ceruso, M, et al.
Publicado: (2023)

Applications of CRISPR-Cas9 in Alzheimer’s Disease and Related Disorders
por: De Plano, Laura M., et al.
Publicado: (2022)

Cas9 has no exonuclease activity resulting in staggered cleavage with overhangs and predictable di- and tri-nucleotide CRISPR insertions without template donor
por: Shi, Xin, et al.
Publicado: (2019)

CRISPR/ddCas12a-based programmable and accurate gene regulation
por: Wang, Jingman, et al.
Publicado: (2019)

Hypercompact CRISPR–Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants
por: Liu, Shishi, et al.
Publicado: (2022)

CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro
por: Liu, Ming, et al.
Publicado: (2023)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Application of CRISPR/Cas9 in Alzheimer’s Disease
por: Lu, Likui, et al.
Publicado: (2021)

Type I-F CRISPR–Cas provides protection from DNA, but not RNA phages
por: Buyukyoruk, Murat, et al.
Publicado: (2019)

A CRISPR-p53 interactome with potential implications for clinical CRISPR/Cas9 use
por: Jiang, Long, et al.
Publicado: (2022)

CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis
por: Shi, Yajun, et al.
Publicado: (2023)

Expanding application of CRISPR-Cas9 system in microorganisms
por: Zhao, Jing, et al.
Publicado: (2020)

Implementation of the CRISPR-Cas9 system in fission yeast
por: Jacobs, Jake Z., et al.
Publicado: (2014)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

The application of CRISPR/Cas9 system in cervical carcinogenesis
por: Gao, Chun, et al.
Publicado: (2021)

The CRISPR/Cas9 System Delivered by Extracellular Vesicles
por: Zhu, Xinglong, et al.
Publicado: (2023)

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
por: Cui, Zifeng, et al.
Publicado: (2022)

WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system
por: Wong, Nathan, et al.
Publicado: (2015)

CRISPR–Cas12a base editors confer efficient multiplexed genome editing in rice
por: Cheng, Yanhao, et al.
Publicado: (2023)

Directed evolution of CRISPR-Cas9 to increase its specificity
por: Lee, Jungjoon K., et al.
Publicado: (2018)

CRISPR/Cas9 Technology and Its Utility for Crop Improvement
por: Liu, Hua, et al.
Publicado: (2022)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vcun149vlqpaku991raep8i9bp